Balancing Accelerated Approval for Drugs With Accelerated Withdrawal Reply

被引:0
|
作者
Kim, Chul [1 ]
Prasad, Vinay [2 ,3 ]
机构
[1] NCI, Med Oncol Serv, NIH, Bethesda, MD 20892 USA
[2] Oregon Hlth & Sci Univ, Div Hematol Oncol, Knight Canc Inst, Portland, OR 97239 USA
[3] Oregon Hlth & Sci Univ, Ctr Hlth Care Eth, Portland, OR 97239 USA
关键词
D O I
10.1001/jamainternmed.2016.0374
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:567 / 567
页数:1
相关论文
共 50 条
  • [21] The Accelerated Approval of Oncologic Drugs Lessons From Ponatinib
    Prasad, Vinay
    Mailankody, Sham
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (04): : 353 - 354
  • [22] Early Accelerated Approval for Highly Targeted Cancer Drugs
    Chabner, Bruce A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (12): : 1087 - 1089
  • [23] Quantification of PFS Effect for Accelerated Approval of Oncology Drugs
    Chen, Cong
    Sun, Linda Z.
    TOPICS IN APPLIED STATISTICS, 2013, 55 : 243 - 256
  • [24] Accelerated Approval and Oncology Drug Development Timelines Reply
    Bennett, Charles L.
    Nebeker, Jonathan R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (14) : E228 - E228
  • [25] Factors in Time to Full Approval or Withdrawal for Anticancer Medicines Granted Accelerated Approval by the FDA
    Tibau, Ariadna
    Hwang, Thomas J.
    Romano, Alejandra
    Borrell, Maria
    Gich, Ignasi
    Molto, Consolacion
    Kesselheim, Aaron S.
    JAMA NETWORK OPEN, 2025, 8 (03)
  • [26] Accelerated approval of bevacizumab
    不详
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (07) : 909 - 909
  • [27] Reforming accelerated approval
    不详
    NATURE BIOTECHNOLOGY, 2012, 30 (04) : 293 - 293
  • [28] Accelerated approval abuse
    Mitka, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (02): : 171 - 171
  • [29] The Accelerated Approval Program for Cancer Drugs - Finding the Right Balance
    Gyawali, Bishal
    Kesselheim, Aaron S.
    Ross, Joseph S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (11): : 968 - 971
  • [30] Medicare Spending on Drugs With Accelerated Approval, 2015-2019
    Rome, Benjamin N.
    Feldman, William B.
    Kesselheim, Aaron S.
    JAMA HEALTH FORUM, 2021, 2 (12): : E213937